Screener
Zevra Therapeutics, Inc. ZVRA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s current ratio?
- Zevra Therapeutics, Inc. (ZVRA) reported current ratio of 5.2× in Q2 2026.
- How has Zevra Therapeutics, Inc.'s current ratio changed year-over-year?
- Zevra Therapeutics, Inc.'s current ratio decreased by 34.2% year-over-year, from 7.9× to 5.2×.
- What is the long-term trend for Zevra Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s current ratio has grown at a 38.5% compound annual growth rate (CAGR), from 1.1× to 5.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Zevra Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude